Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies — Brisa S. Fernandes (2015) | RDL Network
Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies
Article 2015 en
Authors
BF
Brisa S. Fernandes
MM
Marc L. Molendijk
CK
Cristiano A. Köhler
Abstract
1 min read
In summary, our data suggest that peripheral BDNF levels, more clearly in plasma than in serum, is a potential biomarker of disease activity in BD, but not a biomarker of stage. We suggest that peripheral BDNF may, in future, be used as a part of a blood protein composite measure to assess disease activity in BD.
Iría Grande, Inês Chendo, Benício N. Frey, Keila M. Ceresér, Laura Stertz, Gabriela Delevati Colpo, GR Fries, Angelo Batista da Cunha, Eduard Vieta, Flávio Kapczinski
Estela Salagre, Adriana Fernanda K. Vizuete, Marina Concli Leite, D.J. Brownstein, Amelia J. McGuinness, Felice N. Jacka, Seetal Dodd, Brendon Stubbs, C.A. Köhler, Eduard Vieta, A.F. Carvalho, Michael Berk, Brisa S. Fernandes
Gary S. Goldfield, Jameason D. Cameron, Ronald J. Sigal, Glen P. Kenny, Martin Holčı́k, Denis Prud’homme, Eva Guérin, Angela S. Alberga, Amedeo D’Angiulli, Mark S. Tremblay, Fatima Mougharbel, Jeremy J. Walsh
Lara Puhlmann, Roman Linz, Sofie L. Valk, Pascal Vrtička, Reinder Vos de Wael, Andrea Bernasconi, Neda Bernasconi, Benoît Caldairou, Ioannis Papassotiriou, George Chrousos, Boris C. Bernhardt, Tania Singer, Veronika Engert
Discussion(0)
No comments yet. Be the first to comment.